We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Gsk Plc | LSE:GSK | London | Ordinary Share | GB00BN7SWP63 | ORD 31 1/4P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 1,335.00 | 1,333.50 | 1,334.00 | - | 0.00 | 00:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 30.33B | 4.93B | 1.1889 | 11.23 | 55.34B |
Date | Subject | Author | Discuss |
---|---|---|---|
17/1/2022 10:42 | Why now? Don't understand why you would when there is a reasonable chance of an improved offer coming in and the stock is only up 3-4% on that of Friday. | medieval blacksmith | |
17/1/2022 10:42 | Thank you. I sold some thisMorning and will buy again when cheaper | mj19 | |
17/1/2022 10:41 | WILL ELLIOT SELL HIS STAKE TO UNLEVER | notbitcoin | |
17/1/2022 10:40 | Essential - ditto for part of the position. | alphorn | |
17/1/2022 10:33 | I've sold out this morning, the very best to holders. | essentialinvestor | |
17/1/2022 10:25 | MJ19 It will be right up until when it happens. Here is what Med is doing. A Buffett style arbitrage. Buying GSK as an eventual ownership to NewCo. NewCo (IMO) will eventually run a higher PE than GSK pharma. Sell GSK pharma shares towards cost in NewCo. I think natural PE of GSK pharma is lower than that of NewCo. | medieval blacksmith | |
17/1/2022 10:16 | Do we know any details on how long you have to be a shareholder to get shares in the new company when it splits? | mj19 | |
17/1/2022 10:08 | Take money while it's there !! You always get another chance In the stock market | mj19 | |
17/1/2022 09:54 | Unilever trying to get a great company at a dirt cheap price if the world is here in 2 years then glaxo will be 25 pounds a share | jretlaw | |
17/1/2022 09:47 | So you currently hold 3/4m quid in GSK? Jeez, what's your total portfolio value? In any sensible asset allocation, I'd expect £15m? | pierre oreilly | |
17/1/2022 09:39 | Sometimes we should take a Warren Buffett approach. Cash as inflation get traction is trash in the long term. Best get rid of the stuff and buy something with long term wealth creating value. Take a long term view. If I had had the nerve when I was first married to raise lots of debt and buy up as much property as I could afford. It would have been the right thing to do. Don't get hung up on cash, not at this time I history. Think Zimbabwe | careful | |
17/1/2022 09:32 | Gary, Yes, I think you're right and that's why I'm happy to retain 90% of my GSK holding (still a couple of good dividends to come!). However, what I sold was my 'trading' stock, so I have £88K for reinvestment if it dips short term.... o;) | tradermichael | |
17/1/2022 09:30 | You think a pharma company would accept billions of shares in a toothpaste company?Unless it's 80pc ackers, the deal won't be accepted. The reason the bidder is down is because of the billions of debt it will take on to pay us ( well shareholders, probably not you). | pierre oreilly | |
17/1/2022 09:24 | I guess GSK dont want £8 billion in ULVR paper as wont be easy to dispose unless private equity steps in, otherwise cant see ULVR share price recovering for a long while on this deal. | rogerrail | |
17/1/2022 09:23 | TM,Think you could be to early.But a profit is a profit.If GSK hits £20 on improved offer or another bidder. | garycook | |
17/1/2022 09:20 | ULVR shareholders hurting this morning.Bernstein also downgrades to £35. | garycook | |
17/1/2022 09:19 | SOLD, 10% of my holding @ 1727.2 ...... ;0) | tradermichael | |
17/1/2022 09:13 | 90pc that the offer is increased.Ideal is the 50pc chance of flushing out other bidders when we'll get a bidding war. | pierre oreilly | |
17/1/2022 09:08 | They won't come back with another bid!! If shareholders in Unilever are unhappy.When the company splits they can take over the new company when it's floats and bid for that? | mj19 | |
17/1/2022 09:01 | Let's take the money and run and focus on drugs | notbitcoin | |
17/1/2022 08:47 | The lady in charge is wonderful afterall! She knows her Lippo.I wonder if she'll go with the lipstick division?Pure pharma run by experienced pharma people gets high ratings. A double whammy for us. | pierre oreilly | |
17/1/2022 08:43 | So has GSK until recently! | spyder |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions